Eli Lilly to build $470m pharmaceutical manufacturing facility in North Carolina
Eli Lilly is set to invest more than $470m to build a new pharmaceutical manufacturing facility in North Carolina, US....
Civica Rx partners with Thermo Fisher Scientific to develop and manufacture drugs with a history of drug shortages
Civica Rx announced it has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica...
GW expands clinical trial of neoadjuvant immunotherapy for high-risk cutaneous squamous cell carcinoma
The Cutaneous Oncology Program at the George Washington University (GW) Cancer Center was selected as the first global site for...
CSafe Global to present new Cell & Gene cold chain packaging solution at Phacilitate Leaders World
CSafe experts will be on hand to demonstrate the company’s Cell & Gene thermal shipping solution at the Phacilitate Leaders...
Aptar Pharma’s Nasal Unidose Device Again Approved by US FDA for New Nasal Seizure Rescue Treatment
Aptar Pharma, a global leader in drug delivery systems, services and active packaging solutions, announced that its patented Unidose Liquid...
Herbalife Nutrition Launches Beta Heart for Better Cardiovascular Health
Herbalife Nutrition, the global leader in nutrition launches Beta Heart, a new product designed to reduce or maintain cholesterol levels...
Syntegon supplies pharma packaging lines to Pharmax in Dubai
Pharmax was set up to help the UAE become more independent from imported drugs and promote the local production of...
World Courier and ICS Become First End-to-End Specialty Logistics Provider for Advanced Therapies
AmerisourceBergen has enhanced its logistics offering by integrating two of its businesses, World Courier, a global logistics provider, and ICS,...
Catalent to Discuss Ways of Increasing Accuracy and Speed in Assay Development at CASSS WCBP Symposium
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer...
Ascletis Received Approval of Clinical Trials in HBV Patients for ASC22
Ascletis Pharma Inc announces the approval for ASC22 to conduct clinical trials in chronic hepatitis B patients in China from...
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.